MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03880 MEDTIDE

Not Yet Opened 04-16 16:00:00

22.280

+0.180

+0.81%

High22.300	Low21.760	Vol104.40K
Open22.000	D1 Closing22.100	Amplitude2.44%
Mkt Cap3.16B	Tradable Cap3.16B	Total Shares141.80M
T/O2.31M	T/O Rate0.07%	Tradable Shares141.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":22.28,"timestamp":1776326400012,"preClose":22.1,"halted":0,"volume":104400,"delay":0,"changeRate":0.008144796380090484,"floatShares":141800000,"shares":141800000,"eps":1.8693817780629411,"marketStatus":"Not Yet Opened","change":0.18,"latestTime":"04-16 16:00:00","open":22,"high":22.3,"low":21.76,"amount":2310200,"amplitude":0.024434,"askPrice":22.28,"askSize":100,"bidPrice":22.08,"bidSize":100,"shortable":0,"etf":0,"ttmEps":1.946221397161234,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":22.1,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.9862081988566543,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03880/","defaultTab":"news","newsList":[{"id":"2627297342","title":"Precision Peptide grants 800,000 stock options to consultants at $0.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2627297342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627297342?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:31","pubTimestamp":1776339109,"startTime":"0","endTime":"0","summary":"Precision Peptide Company granted 800,000 stock options to certain consultants under its omnibus long-term incentive plan.Options carry an exercise price of $0.5 per common share.Terms run from one year to three years from grant date.Shares issued on option exercise will be subject to a four-month hold period from grant date.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL5l8fng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117575956","title":"Medtide Doubles Issued Share Capital to 141.80 Million Shares through Conversion of 68.20 Million Unlisted Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1117575956","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117575956?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:00","pubTimestamp":1775642459,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for Equity Issuer for March 2026, detailing a major capital restructuring that brings all outstanding shares onto The Stock Exchange of Hong Kong (HKEX). Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624080539","title":"Medtide (SEHK:3880) Net Margin Surge In 1H FY 2025 Tests Earnings Quality Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2624080539","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624080539?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963251,"startTime":"0","endTime":"0","summary":"Medtide (SEHK:3880) has just posted its FY 2025 first half numbers, with revenue of ¥253.8 million and basic EPS of ¥0.82, set against trailing twelve month revenue of ¥570.1 million and EPS of ¥1.63 that sit alongside a reported year over year earnings growth figure of 267.3%. Over recent periods the company has seen revenue move from ¥197.5 million and EPS of ¥0.40 in the first half of FY 2024 to ¥244.8 million and EPS of ¥0.07 in the second half of FY 2024 and then to the latest ¥253.8...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-net-margin-surge-in-1h-fy-2025-tests-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-net-margin-surge-in-1h-fy-2025-tests-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176842672","title":"Medtide 2025 Results: Revenue Reaches RMB570.09 Million, Net Profit Soars 267.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176842672","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176842672?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:46","pubTimestamp":1774874819,"startTime":"0","endTime":"0","summary":"Medtide Inc. released its audited results for the year ended 31 December 2025. Revenue increased 28.9% year-on-year to RMB570.09 million, driven mainly by strong growth in CDMO services. Net profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176147559","title":"Medtide Proposes Articles Revision and Scraps Supervisory Committee in Line with New PRC Company Law","url":"https://stock-news.laohu8.com/highlight/detail?id=1176147559","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176147559?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:46","pubTimestamp":1774874818,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock short name: MEDTIDE) announced that its Board of Directors resolved on 30 March 2026 to overhaul the company’s governance framework by amending its Articles of Association and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623131044","title":"Medtide proposes bylaw amendments to replace supervisory committee with board audit committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2623131044","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623131044?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:42","pubTimestamp":1774874555,"startTime":"0","endTime":"0","summary":"Medtide set proposed amendments to articles of association for shareholder vote at a forthcoming annual general meeting.Changes would abolish supervisory committee, shifting its functions to board audit committee under revised PRC Company Law effective July 1, 2024.Package also targets stronger shareholder protections, aligning governance rules with updated PRC regulations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL9HRwvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623912310","title":"Medtide Inc -  Profit for Year RMB217.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623912310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623912310?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:38","pubTimestamp":1774874282,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I0LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623310914","title":"Medtide FY25 profit jumps to RMB 217 million; revenue rises 28.9% to RMB 570 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623310914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623310914?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:37","pubTimestamp":1774874272,"startTime":"0","endTime":"0","summary":"Medtide posted profit for the year of RMB 220 million, tripling from a year earlier.Gross margin widened 6.9 percentage points to 63.4%.Listing in June 2025 expanded cash and cash equivalents to RMB 890 million; gearing ratio fell to 12.6%.Capacity expansion in Hangzhou is set to start up in 1Q 2026, lifting total API production capacity to over one metric ton per year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLCGGyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153266924","title":"Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1153266924","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153266924?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:01","pubTimestamp":1773673303,"startTime":"0","endTime":"0","summary":"Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes: • Reviewing and approving the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619464526","title":"Medtide Inc. schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464526","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464526?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:48","pubTimestamp":1773672499,"startTime":"0","endTime":"0","summary":"Medtide will hold a board meeting on March 30, 2026 to consider and approve its annual results for the year ended December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL1SWGJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194292","title":"Pangea Wellness to Rename as The Precision Peptide Company on March 18, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194292?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:08","pubTimestamp":1773403731,"startTime":"0","endTime":"0","summary":"Pangea said it will change its name to The Precision Peptide Company. The company said its shares are expected to trade on the CSE under the symbol BPC. Pangea also reported a new CUSIP of 74031F104 and a new ISIN of CA74031F1045.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL9ZBhXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618662443","title":"Medtide Completes Hong Kong-Listed Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2618662443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618662443?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:05","pubTimestamp":1773065152,"startTime":"0","endTime":"0","summary":"Medtide (HKG:3880) completed the conversion of 68.2 million unlisted shares into Hong Kong-listed shares on Monday, according to a same-day Hong Kong bourse filing.The listing of the peptide-focused CRDMO's converted shares on the Hong Kong stock exchange will begin at 9:00 am on March 10.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145434260","title":"MEDTIDE Completes Conversion of Domestic Shares to H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1145434260","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145434260?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:10","pubTimestamp":1773058229,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced the successful conversion of 68.2011 million non-tradable shares into H shares, which was finalized on March 9, 2026. The converted H shares are scheduled to commence trading on the Stock Exchange of Hong Kong starting at 9:00 a.m. on March 10, 2026.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132041759","title":"MEDTIDE (03880.HK) Completes H-Share Full Circulation; 68.20 Million Domestic Shares Converted, Free Float Rises to 100%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132041759","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132041759?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:03","pubTimestamp":1773057798,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880.HK) announced the completion of its H-share full-circulation programme, converting 68.20 million previously unlisted domestic shares into H shares. Trading in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162073233","title":"MEDTIDE (03880) Announces February 2026 Monthly Return with No Change in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1162073233","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162073233?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:22","pubTimestamp":1772616156,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) disclosed its February 2026 monthly return, confirming that the company’s total issued share capital remained at 141.80 million shares. Of these, 73.60 million are H shares and 68.20...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160058425","title":"MEDTIDE's Annual Profit Surge Fails to Impress Amid 50% Stock Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=1160058425","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160058425?lang=en_us&edition=fundamental","pubTime":"2026-02-28 16:01","pubTimestamp":1772265682,"startTime":"0","endTime":"0","summary":"On February 26, before market opening, MEDTIDE (03880) issued a profit alert for the 2025 fiscal year. According to the announcement, the company anticipates revenue to be between 555 million and 585...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614698960","title":"BRIEF-Medtide Sees Revenue For Year Within Range Of Rmb555 Million To Rmb585 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614698960","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614698960?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:20","pubTimestamp":1772068853,"startTime":"0","endTime":"0","summary":"BRIEF-Medtide Sees Revenue For Year Within Range Of Rmb555 Million To Rmb585 MillionFeb 26  - Medtide Inc 3880.HK:SEES  REVENUE FOR YEAR WITHIN RANGE OF RMB555 MILLIO TO RMB585 MILLIONSEES  PROFIT FOR YEAR  WITHIN RANGE OF RMB200 MILLION TO RMB230 MILLIONFurther company coverage: 3880.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZL28N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162146850","title":"Medtide Inc. (Stock Code: 3880) Announces Positive Profit Alert","url":"https://stock-news.laohu8.com/highlight/detail?id=1162146850","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162146850?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:21","pubTimestamp":1772065266,"startTime":"0","endTime":"0","summary":"Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188288091","title":"MEDTIDE Issues Profit Alert, Forecasts Adjusted Net Profit Between RMB200 Million and RMB230 Million for Fiscal Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1188288091","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188288091?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:20","pubTimestamp":1772065227,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced an optimistic profit forecast. The group anticipates revenue for the fiscal year ending December 31, 2025, to be approximately RMB555 million to RMB585 million. This...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614063825","title":"Medtide Inc  Sees  Revenue for Year Within Range of RMB555 Millio to RMB585 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614063825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614063825?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:01","pubTimestamp":1772064066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZL28N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medtideinc.com","stockEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":-0.0313},{"period":"3month","weight":-0.2193},{"period":"6month","weight":-0.2573},{"period":"1year","weight":-0.2719},{"period":"ytd","weight":-0.269}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0203},{"period":"3month","weight":-0.0168},{"period":"6month","weight":0.0454},{"period":"1year","weight":0.2535},{"period":"ytd","weight":0.0298}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.","exchange":"SEHK","name":"MEDTIDE","nameEN":"MEDTIDE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MEDTIDE,03880,MEDTIDE股票,MEDTIDE股票老虎,MEDTIDE股票老虎国际,MEDTIDE行情,MEDTIDE股票行情,MEDTIDE股价,MEDTIDE股市,MEDTIDE股票价格,MEDTIDE股票交易,MEDTIDE股票购买,MEDTIDE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}